Dear Friends,

Codex was proud to organise a thought-provoking event that examined the latest advances in artificial intelligence which are revolutionising the pharmaceutical industry, offering unprecedented opportunities for innovation in drug discovery and design. This was a timely event that examined the key challenges and opportunities of advanced artificial intelligence and quantum technologies in drug design and discovery.

Panellists

Tim Guilliams, Co-founder and CEO, Healx
Elise de Reus, Co-founder, Cradle
Rodrigo Barnes, CTO, Owkin
Elsi-Mari Borrelli, Head of Partnerships, Algorithmiq
Jan Gerit Brandenburg, Director for Digital Chemistry, Merck Group

A big thank you to Merck KGaA, Darmstadt, Germany for hosting.

Full version of the panel discussion video is available click here

Highlights video is available click here

Key topics panellists discussed:

The role of AI in protein design and protein structure prediction;
The AI driven drug discovery process;
How can AI help predict the dynamic behaviour of proteins;
Personalised medicine and precision drug design;
Ethics and regulation in AI-driven drug discovery;
How academic research, pharmaceutical companies, and AI start-ups can collaborate to accelerate the adoption of AI in drug discovery;
Quantum Computing and AI: Exploring how advances in quantum computing could further revolutionise protein design and protein folding predictions and drug discovery.

This event provided an excellent opportunity to engage in thought-provoking discussions, and network with technology leaders and influential investors, exploring the role AI will play in shaping healthcare.

Codex – Honouring great innovators for 20 years learn more